About the contributors
 

Foreword.................................................................................................................................
 

The evolving treatment of chronic hepatitis C: Where we stand a decade out............
SHERIF SAADEH, MD, AND GARY L. DAVIS, MD
 

Initial treatment for chronic hepatitis C: Current therapies and their optimal
dosing and duration...............................................................................................................
KEYUR PATEL, MD, AND JOHN G. MCHUTCHISON, MD
 

Retreatment of patients who do not respond to initial therapy for chronic
hepatitis C................................................................................................................................
MITCHELL L. SHIFFMAN, MD
 

Managing the hematologic side effects of antiviral therapy for chronic hepatitis C:
Anemia, neutropenia, and thrombocytopenia.................................................................
JANUS P. ONG, MD, AND ZOBAIR M. YOUNOSSI, MD, MPH
 

The role of hematopoietic growth factors in special populations with chronic
hepatitis C: Patients with HIV coinfection, end-stage renal disease, or liver
transplantation.......................................................................................................................
STEVAN A. GONZALEZ, MD, AND IRA M. JACOBSON, MD
 

Managing the neuropsychiatric side effects of interferon-based therapy for
hepatitis C................................................................................................................................
CATHERINE C. CRONE, MD; GEOFFREY M. GABRIEL, MD; AND THOMAS N. WISE, MD
 

The role of physician extenders in managing patients with chronic hepatitis C........
HARPREET GUJRAL, RN, MSN, CRNP; CARLA VISCOMI, RN, BSN; AND ROCHELLE
COLLANTES, MD, MPH

Copyright© 2004 The Cleveland Clinic Foundation.

The statements and opinions expressed in this supplement to the Cleveland Clinic Journal of Medicine are those of the authors and not necessarily of The Cleveland Clinic Foundation, its Board of Trustees, or Amgen Inc.

The Cleveland Clinic Journal of Medicine (ISSN 0891-1150) is published 12 times yearly by the Cleveland Clinic Foundation.

Subscription rates: U.S. and possessions: personal $98; institutional $124; single copy/back issue $16. Foreign: $124; single copy/back issue $16. Institutional (multiple-reader rate) applies to libraries, schools, hospitals, and federal, commercial, and private institutions and organizations. Individual subscriptions must be in the names of, billed to, and paid by individuals.

Postmaster address changes: Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195. Subscription orders, editorial, reprint, and production offices (same address): Phone (216) 444-2661; Fax (216) 444-9385; E-mail, ccjm@ccf.org; World Wide Web address: http://www.ccjm.org

Printed in USA.